Phase I trial of ITI 007 in volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Lumateperone (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Intra-Cellular Therapies
- 22 Dec 2009 Status changed from recruiting to completed according to an Intra-Cellular Therapies media release.
- 16 Jan 2009 Status changed from not yet recruiting to recruiting.
- 29 Jun 2007 New trial record.